Prelude Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Buy |
+27,511
| New | +$593K | 0.06% | 387 |
|
|
2024
Q1 | – | Sell |
-16,595
| Closed | -$520K | – | 1170 |
|
|
2023
Q4 | $520K | Buy |
16,595
+5,727
| +53% | +$179K | 0.03% | 418 |
|
|
2023
Q3 | $226K | Buy |
+10,868
| New | +$226K | 0.01% | 701 |
|
|
2020
Q3 | – | Sell |
-362
| Closed | -$18K | – | 1315 |
|
|
2020
Q2 | $18K | Buy |
+362
| New | +$18K | ﹤0.01% | 955 |
|
|
2020
Q1 | – | Sell |
-884
| Closed | -$38K | – | 908 |
|
|
2019
Q4 | $38K | Buy |
+884
| New | +$38K | ﹤0.01% | 1020 |
|
|
2019
Q3 | – | Sell |
-1,355
| Closed | -$36K | – | 1149 |
|
|
2019
Q2 | $36K | Sell |
1,355
-584
| -30% | -$15.5K | ﹤0.01% | 848 |
|
|
2019
Q1 | $52K | Buy |
+1,939
| New | +$52K | ﹤0.01% | 778 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1333 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1323 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1450 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1444 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1461 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1486 |
|
|
2014
Q1 | – | Sell |
-23,020
| Closed | -$575K | – | 1624 |
|
|
2013
Q4 | $575K | Hold |
23,020
| – | – | 0.09% | 272 |
|
|
2013
Q3 | $632K | Sell |
23,020
-34,980
| -60% | -$960K | 0.1% | 201 |
|
|
2013
Q2 | $1.05M | Buy |
+58,000
| New | +$1.05M | 0.23% | 80 |
|